Pfizer Inc. (NYSE:PFE) is one of the best medical stocks to buy now. In a report released on September 29, Carter Gould from Cantor Fitzgerald maintained a Hold rating on Pfizer Inc. (NYSE:PFE) and set a price target of $24.00. Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets, and sells biopharmaceutical products worldwide. While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.